EBV特异性T细胞 (Yongtai)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEBV特异性T细胞 (Yongtai)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > TCR therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsEpstein-Barr Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImmunotech Applied Science Ltd
China Registration ClassN/A

Develop Information

Active CompaniesImmunotech Applied Science Ltd
Inactive CompaniesN/A
Active IndicationsEpstein-Barr Virus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A